NASDAQ: COAG · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Hemab Therapeutics Holdings Inc.

How Hemab Therapeutics Holdings Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$1.9B

Price

$40.42

P/E

-25.4

EPS (TTM)

$-1.59

Dividend yield

0.0%

52-week range

$28.70–$40.42

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources